Recent advances in the treatment of chronic heart failure [version 1; peer review: 3 approved]
After more than a decade of relatively modest advancements, heart failure therapeutic development has accelerated, with the PARADIGM-HF trial and the SHIFT trial demonstrated significant reductions in cardiovascular death and heart failure hospitalization for sacubitril-valsartan and in heart failur...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2019-12-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/8-2134/v1 |